| Financial Year |
March 31 2023 |
| Monetary Funds |
2,080,804,954.87 |
| Held-for-trading Financial Assets |
96,797,345.05 |
| Notes Receivable |
304,209,812.37 |
| Accounts Receivable |
1,488,104,090.44 |
| Advances to Suppliers |
104,945,627.45 |
| Other Receivables |
3,920,146.27 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
613,782,995.07 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
33,488,756.95 |
| Other Current Assets |
106,262,321.82 |
| Total Current Assets |
5,143,642,111.71 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
18,004,687.16 |
| Investment Properties |
-- |
| Fixed Assetes |
1,614,195,723.40 |
| Under-construction Projects |
406,809,733.53 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
277,676,906.91 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
745,395.04 |
| Deferred Income Tax Assets |
24,445,388.21 |
| Other Non-Current Assets |
61,411,090.79 |
| Sub-Total of Non-Current Assets |
2,406,063,854.50 |
| Total Assets |
7,549,705,966.21 |
| Short-Term Loans |
100,686,992.92 |
| Trading Financial liabilities |
-- |
| Notes Payable |
56,276,484.19 |
| Accounts Payable |
346,330,531.55 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
38,318,244.58 |
| Taxes Payable |
40,759,630.99 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
7,024,938.26 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,776,495.51 |
| Other Current Liabilities |
72,432,872.23 |
| Sub-Total of Current Liabilities |
675,508,729.34 |
| Long-term Loans |
60,000,000.00 |
| Bonds Payable |
962,785,137.69 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
29,980,058.11 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,096,077,509.11 |
| Total Liabilities |
1,771,586,238.45 |
| Paid-In Capital(Or Share Stock) |
1,250,169,663.00 |
| Capital Surplus |
1,877,205,511.07 |
| Surplus Reserve |
305,826,818.84 |
| LESS:Treasury Stock |
150,228,907.41 |
| Undistributed Profits |
2,291,545,502.03 |
| Minority Stockholder's Interest |
28,005,470.25 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,750,114,257.51 |
| Owner's Equity（Stockholder's Equity） |
5,778,119,727.76 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,549,705,966.21 |
